Entera Bio Ltd. (ENTX)
NASDAQ: ENTX
· Real-Time Price · USD
1.99
0.02 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.00
0.50%
After-hours: Aug 15, 2025, 07:57 PM EDT
Entera Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 42K | 82K | 42K | 57K | n/a | 4.48M | n/a | n/a | n/a | 14K | 8K | 44K | 68K | 165K | 140K | 109K | 157K |
Cost of Revenue | 42K | 82K | 42K | 48K | 13K | 13K | 14K | 15K | 2.21M | 8K | 6K | 33K | 54K | 187K | 65K | 63K | 73K |
Gross Profit | n/a | n/a | n/a | 9K | -13K | 4.47M | -14K | -15K | -2.21M | 6K | 2K | 11K | 14K | -22K | 75K | 46K | 84K |
Operating Income | n/a | -2.34M | -3.02M | -2.17M | -2.06M | -1.97M | -2.39M | -2.33M | 2.21M | -3.07M | -2.87M | -3.25M | -3.83M | -4.12M | -3.09M | -2.65M | -2.34M |
Interest Income | n/a | n/a | n/a | 20K | 45K | n/a | 36K | 5K | 22K | n/a | n/a | n/a | 44K | n/a | n/a | n/a | 29K |
Pretax Income | 2.57M | -2.34M | -3.02M | -2.15M | -2.02M | -2M | -2.35M | -2.33M | -2.19M | -2.89M | -2.86M | -3.19M | -3.79M | 4.73M | -2.42M | -5.11M | -2.31M |
Net Income | 2.57M | -2.36M | -3.02M | -2.15M | -2.02M | -2M | -2.38M | -2.33M | 2.23M | -3.21M | -2.66M | -3.19M | -3.78M | 4.92M | -2.46M | -5.15M | -2.3M |
Selling & General & Admin | 1.44M | 1.14M | 1.54M | 1.09M | 1.33M | 973K | 1.03M | 1.14M | 1.29M | 1.74M | 1.46M | 1.88M | 2.17M | 1.48M | 1.45M | 1.45M | 1.31M |
Research & Development | 1.12M | 1.2M | 1.48M | 1.09M | 722K | 987K | 1.37M | 1.21M | 931K | 1.35M | 1.41M | 1.39M | 1.69M | 2.63M | 1.73M | 1.26M | 1.12M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -13K | -18K | -6K | n/a | -12K | 23K | n/a | n/a | n/a |
Operating Expenses | 2.56M | 2.34M | 3.02M | 2.17M | 2.05M | 1.96M | 2.39M | 2.33M | 2.21M | 3.07M | 2.87M | 3.26M | 3.85M | 4.09M | 3.17M | 2.7M | 2.42M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.6M | 2.42M | 3.06M | 2.22M | 2.06M | 1.97M | 2.39M | 2.33M | 2.21M | 3.08M | 2.87M | 3.29M | 3.9M | 4.28M | 3.23M | 2.76M | 2.5M |
Income Tax Expense | n/a | 14K | -6.04M | n/a | n/a | n/a | 29K | n/a | -4.42M | 320K | -194K | -4K | -7K | -182K | 45K | 40K | -14K |
Shares Outstanding (Basic) | 43.38M | 37.65M | 37.64M | 37.09M | 36.74M | 29.7M | 28.81M | 28.81M | 28.81M | 28.81M | 28.81M | 28.81M | 28.8M | 28.68M | 28.68M | 24.72M | 21.89M |
Shares Outstanding (Diluted) | 43.38M | 37.65M | 37.64M | 37.09M | 36.74M | 29.7M | 28.81M | 28.81M | 28.81M | 28.81M | 28.81M | 28.81M | 28.8M | 28.68M | 28.68M | 24.72M | 21.89M |
EPS (Basic) | 0.06 | -0.06 | 0.08 | -0.06 | -0.05 | -0.07 | -0.08 | -0.08 | 0.08 | -0.11 | -0.09 | -0.11 | -0.13 | 1.02 | -0.09 | -0.21 | -0.1 |
EPS (Diluted) | 0.06 | -0.06 | 0.08 | -0.06 | -0.05 | -0.07 | -0.08 | -0.08 | 0.08 | -0.11 | -0.09 | -0.11 | -0.13 | 1.02 | -0.09 | -0.21 | -0.1 |
EBITDA | n/a | -2.33M | -3.01M | -2.15M | -2.05M | -1.95M | -2.37M | -2.31M | -2.2M | -3.05M | -2.85M | -3.26M | -3.82M | 4.73M | -3.21M | -2.56M | -2.33M |
EBIT | n/a | -2.34M | -3.02M | -2.17M | -2.06M | -1.96M | -2.39M | -2.33M | -2.21M | -3.07M | -2.87M | -3.25M | -3.83M | -4.12M | -3.22M | -2.57M | -2.34M |
Depreciation & Amortization | n/a | 11K | 11K | 11K | 13K | 13K | 14K | 15K | 14K | 16K | 16K | 16K | 16K | -129K | 32K | 59K | 91K |